ASCO GU 2019: Gemcitabine + Axitinib Shows Promising Efficacy in Sarcomatoid Renal Cell Carcinoma
Though confirmation is needed, gemcitabine may come to be considered a treatment option for sarcomatoid renal cell carcinoma.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.